SUSAN MAGADAN: Open Payments
NPI 1508929969 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 45 payments from 24 companies in 2025. Trend: 2023 $197 · 2024 $272 · 2025 $942
Food & beverage: $849Education: $93
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $128 |
| SEAGEN INC. | 1 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $88 |
| Exelixis Inc. | 2 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| GENZYME CORPORATION | 2 | $45 |
| Janssen Biotech, Inc. | 2 | $44 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $44 |
| Lilly USA, LLC | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $39 |
Products named: Nubeqa, CABOMETYX, PADCEV, TALVEY, ZYNLONTA, VERZENIO, KEYTRUDA, CALQUENCE.
Industry payments across NV — which companies pay providers there.
